We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Healthcare Inv | LSE:HIO | London | Ordinary Share | GB00B94T6Y14 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 14.75 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMCOS
Collagen Solutions PLC
18 February 2019
Collagen Solutions Plc
(the "Company")
Presenting at the Hardman Investor Forum
Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that Jamal Rushdy will be presenting at an investor evening hosted by Hardman & Co on Tuesday, 26 February at DAC Beachcroft, 100 Fetter Lane, London EC4A 1BN.
The event provides an opportunity for investors to hear about the progress being made by the Company and the potential for its own products going forward. Jamal Rushdy will give a 15 minute presentation followed by a 10 minute Q&A session. Registration is from 5.30pm for a prompt start at 6.00pm.
To register for the event and obtain further details, please contact Grace Merrall at Hardman & Co on gm@hardmanandco.com
No new material information will be disclosed. Presentation slides will be available after the event on the Company website at http://ir.collagensolutions.com/content/investors/presentations.asp
Enquiries:
Collagen Solutions Plc Jamal Rushdy, CEO Via Walbrook Hilary Spence, CFO Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com Anna Dunphy Mob: 07876 741 001 Helen Cresswell Mob: 07841 917 679
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NRAGCGDDDXBBGCU
(END) Dow Jones Newswires
February 18, 2019 02:01 ET (07:01 GMT)
1 Year Healthcare Inv Chart |
1 Month Healthcare Inv Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
